These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 24339227)

  • 21. Structure-activity relationship of 5-chloro-2-methyl-3-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indole analogues as 5-HT(6) receptor agonists.
    Mattsson C; Svensson P; Boettcher H; Sonesson C
    Eur J Med Chem; 2013 May; 63():578-88. PubMed ID: 23542166
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis of some tropane derivatives of anticipated activity on the reuptake of norepinephrine and/or serotonin.
    Hanna MM; Eid NM; George RF; Safwat HM
    Bioorg Med Chem; 2007 Dec; 15(24):7765-72. PubMed ID: 17870537
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel pyridyl-fused 3-amino chroman derivatives with dual action at serotonin transporter and 5-HT1A receptor.
    Zhou D; Hatzenbuhler NT; Gross JL; Harrison BL; Evrard DA; Chlenov M; Golembieski J; Hornby G; Schechter LE; Smith DL; Andree TH; Stack GP
    Bioorg Med Chem Lett; 2007 Jun; 17(11):3117-21. PubMed ID: 17407811
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dual 5-HT1A agonists and 5-HT re-uptake inhibitors by combination of indole-butyl-amine and chromenonyl-piperazine structural elements in a single molecular entity.
    Heinrich T; Böttcher H; Schiemann K; Hölzemann G; Schwarz M; Bartoszyk GD; van Amsterdam C; Greiner HE; Seyfried CA
    Bioorg Med Chem; 2004 Sep; 12(18):4843-52. PubMed ID: 15336263
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selective, centrally acting serotonin 5-HT2 antagonists. 2. Substituted 3-(4-fluorophenyl)-1H-indoles.
    Andersen K; Perregaard J; Arnt J; Nielsen JB; Begtrup M
    J Med Chem; 1992 Dec; 35(26):4823-31. PubMed ID: 1336054
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Advances toward new antidepressants with dual serotonin transporter and 5-HT1A receptor affinity within a class of 3-aminochroman derivatives. Part 2.
    Hatzenbuhler NT; Baudy R; Evrard DA; Failli A; Harrison BL; Lenicek S; Mewshaw RE; Saab A; Shah U; Sze J; Zhang M; Zhou D; Chlenov M; Kagan M; Golembieski J; Hornby G; Lai M; Smith DL; Sullivan KM; Schechter LE; Andree TH
    J Med Chem; 2008 Nov; 51(21):6980-7004. PubMed ID: 18834188
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Studies on a series of milnacipran analogs containing a heteroaromatic group as potent norepinephrine and serotonin transporter inhibitors.
    Vickers T; Dyck B; Tamiya J; Zhang M; Jovic F; Grey J; Fleck BA; Aparicio A; Johns M; Jin L; Tang H; Foster AC; Chen C
    Bioorg Med Chem Lett; 2008 Jun; 18(11):3230-5. PubMed ID: 18468895
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel Azido-Iodo Photoaffinity Ligands for the Human Serotonin Transporter Based on the Selective Serotonin Reuptake Inhibitor (S)-Citalopram.
    Kumar V; Yarravarapu N; Lapinsky DJ; Perley D; Felts B; Tomlinson MJ; Vaughan RA; Henry LK; Lever JR; Newman AH
    J Med Chem; 2015 Jul; 58(14):5609-19. PubMed ID: 26153715
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Studies towards the next generation of antidepressants. Part 4: derivatives of 4-(5-fluoro-1H-indol-3-yl)cyclohexylamine with affinity for the serotonin transporter and the 5-HT1A receptor.
    Evrard DA; Zhou P; Yi SY; Zhou D; Smith DL; Sullivan KM; Hornby GA; Schechter LE; Andree TH; Mewshaw RE
    Bioorg Med Chem Lett; 2005 Feb; 15(4):911-4. PubMed ID: 15686885
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Design, synthesis and bioactivity of aryl piperazine benzo[b][1,4]oxazine derivatives].
    Zheng YY; Xie P; Zhang J; Li JQ; Guo L; Yu LP; Zhou B
    Yao Xue Xue Bao; 2012 Jun; 47(6):755-63. PubMed ID: 22919723
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sigma ligands with subnanomolar affinity and preference for the sigma 2 binding site. 1. 3-(omega-aminoalkyl)-1H-indoles.
    Perregaard J; Moltzen EK; Meier E; Sánchez C
    J Med Chem; 1995 May; 38(11):1998-2008. PubMed ID: 7783131
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.
    Park JE; Song C; Choi K; Sim T; Moon B; Roh EJ
    Bioorg Med Chem Lett; 2013 Oct; 23(20):5515-8. PubMed ID: 24012181
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and evaluation of 2-(2-arylmorpholino)ethyl esters of ibuprofen hydrochlorides as COX-2 and serotonin reuptake inhibitors.
    Dou J; Shi L; Hu A; Dong M; Xu J; Liu A; Jiang Y
    Arch Pharm (Weinheim); 2014 Feb; 347(2):89-95. PubMed ID: 24243443
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and Docking of Novel 3-Indolylpropyl Derivatives as New Polypharmacological Agents Displaying Affinity for 5-HT
    Pessoa-Mahana H; Silva-Matus P; Pessoa-Mahana CD; Chung H; Iturriaga-Vásquez P; Quiroz G; Möller-Acuña P; Zapata-Torres G; Saitz-Barría C; Araya-Maturana R; Reyes-Parada M
    Arch Pharm (Weinheim); 2017 Jan; 350(1):. PubMed ID: 27981607
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New 1-aryl-3-(4-arylpiperazin-1-yl)propane derivatives, with dual action at 5-HT1A serotonin receptors and serotonin transporter, as a new class of antidepressants.
    Martínez-Esparza J; Oficialdegui AM; Pérez-Silanes S; Heras B; Orús L; Palop JA; Lasheras B; Roca J; Mourelle M; Bosch A; Del Castillo JC; Tordera R; Del Río J; Monge A
    J Med Chem; 2001 Feb; 44(3):418-28. PubMed ID: 11462981
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and evaluation of novel 2,3-dihydrobenzo[b][1,4]dioxin- and indolealkylamine derivatives as potential antidepressants.
    Wang S; Chen Y; Liu X; Xu X; Liu X; Liu BF; Zhang G
    Arch Pharm (Weinheim); 2014 Jan; 347(1):32-41. PubMed ID: 24214603
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and molecular modeling of new 1-aryl-3-[4-arylpiperazin-1-yl]-1-propane derivatives with high affinity at the serotonin transporter and at 5-HT(1A) receptors.
    Orús L; Pérez-Silanes S; Oficialdegui AM; Martínez-Esparza J; Del Castillo JC; Mourelle M; Langer T; Guccione S; Donzella G; Krovat EM; Poptodorov K; Lasheras B; Ballaz S; Hervías I; Tordera R; Del Río J; Monge A
    J Med Chem; 2002 Sep; 45(19):4128-39. PubMed ID: 12213056
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis, molecular docking and binding studies of selective serotonin transporter inhibitors.
    Nencetti S; Mazzoni MR; Ortore G; Lapucci A; Giuntini J; Orlandini E; Banti I; Nuti E; Lucacchini A; Giannaccini G; Rossello A
    Eur J Med Chem; 2011 Mar; 46(3):825-34. PubMed ID: 21272963
    [TBL] [Abstract][Full Text] [Related]  

  • 39. From the selective serotonin transporter inhibitor citalopram to the selective norepinephrine transporter inhibitor talopram: synthesis and structure-activity relationship studies.
    Eildal JN; Andersen J; Kristensen AS; Jørgensen AM; Bang-Andersen B; Jørgensen M; Strømgaard K
    J Med Chem; 2008 May; 51(10):3045-8. PubMed ID: 18429609
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and monoamine transporter affinity of new 2beta-carbomethoxy-3beta-[4-(substituted thiophenyl)]phenyltropanes: discovery of a selective SERT antagonist with picomolar potency.
    Tamagnan G; Alagille D; Fu X; Kula NS; Baldessarini RJ; Innis RB; Baldwin RM
    Bioorg Med Chem Lett; 2005 Feb; 15(4):1131-3. PubMed ID: 15686927
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.